DTE
20
-9
DVA
52
-4
ADP
53
-2
FTI
28
-4
GWW
41
-3
PGR
45
10
PEP
30
-3
ISRG
50
2
CME
36
-10
T
53
2
AMGN
21
11
ED
31
-6
CB
51
12
BF.B
39
4
HRL
30
-2
VNO
33
-4
ORLY
40
-10
CHD
39
-4
NUE
22
3
UNP
15
-11
DTE
20
-9
DVA
52
-4
ADP
53
-2
FTI
28
-4
GWW
41
-3
PGR
45
10
PEP
30
-3
ISRG
50
2
CME
36
-10
T
53
2
AMGN
21
11
ED
31
-6
CB
51
12
BF.B
39
4
HRL
30
-2
VNO
33
-4
ORLY
40
-10
CHD
39
-4
NUE
22
3
UNP
15
-11
Financhill
Back

PT Bank Central Asia Tbk Vs. SpringWorks Therapeutics Industry Stock Comparison

Sell
44

PBCRF
PT Bank Central Asia Tbk

Last Price:
$0.51
Seasonality Move:
3.87%
Sell
11

SWTX
SpringWorks Therapeutics

Last Price:
$35.50
Seasonality Move:
5.59%
Sell
44
PT Bank Central Asia Tbk (PBCRF) is a Sell

Is PT Bank Central Asia Tbk a Buy, Sell or Hold?

  • The current PT Bank Central Asia Tbk [PBCRF] share price is $0.51. The Score for PBCRF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • PBCRF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $36.99. The Score for SWTX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PBCRF Stock Price Chart

What is PT Bank Central Asia Tbk's stock price today?

  • The PT Bank Central Asia Tbk share price today is $0.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBCRF is experiencing slight buying pressure.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $36.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing slight selling pressure.

PBCRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 48.33 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.48 - 0.54) Sell
Bollinger Bands (100): (0.52 - 0.62) Sell

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.41 Sell
Relative Strength Index (14 RSI): 31.76 Sell
Chaikin Money Flow: -1228444 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.93 - 51.91) Sell
Bollinger Bands (100): (35.17 - 50.17) Sell

PBCRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.51 Sell
20-day SMA: 0.5 Buy
50-day SMA: 0.53 Sell
200-day SMA: 0.61 Sell
8-day EMA: 0.51 Buy
20-day EMA: 0.51 Buy
50-day EMA: 0.53 Sell
200-day EMA: 0.59 Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.32 Sell
20-day SMA: 47.1 Sell
50-day SMA: 47.64 Sell
200-day SMA: 39.14 Sell
8-day EMA: 42.51 Sell
20-day EMA: 45.83 Sell
50-day EMA: 46.19 Sell
200-day EMA: 41.19 Sell

PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $2.06 per share.

PT Bank Central Asia Tbk Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):